M
0.820
-0.05 (-5.61%)
| Penutupan Terdahulu | 0.869 |
| Buka | 0.847 |
| Jumlah Dagangan | 431,999 |
| Purata Dagangan (3B) | 5,625,227 |
| Modal Pasaran | 10,908,050 |
| Harga / Buku (P/B) | 2.33 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 May 2025 - 12 May 2025 |
| EPS Cair (TTM) | -6.32 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 7.99% |
| Nisbah Semasa (MRQ) | 0.970 |
| Aliran Tunai Operasi (OCF TTM) | -23.86 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -14.36 M |
| Pulangan Atas Aset (ROA TTM) | -60.39% |
| Pulangan Atas Ekuiti (ROE TTM) | -135.80% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Moleculin Biotech, Inc. | Menurun | Menurun |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 1.00 |
|
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company’s Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.72% |
| % Dimiliki oleh Institusi | 3.39% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Atticus Wealth Management, Llc | 31 Dec 2024 | 2,784 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 8.00 (HC Wainwright & Co., 875.61%) | Beli |
| Median | 6.00 (631.71%) | |
| Rendah | 4.00 (Maxim Group, 387.81%) | Beli |
| Purata | 6.00 (631.71%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 1.15 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 25 Mar 2025 | 8.00 (875.61%) | Beli | 1.15 |
| 24 Mar 2025 | 8.00 (875.61%) | Beli | 1.06 | |
| Maxim Group | 25 Mar 2025 | 4.00 (387.80%) | Beli | 1.15 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |